Court dismisses class action suit against Mylan regarding EpiPen

Viatris said it will continue to “defend itself vigorously should there be any further proceedings in the case.”
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.